Signal #149862 · SEC 8-K

$ELAB SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ELAB filing catalyst

Why did $ELAB trigger an AI stock catalyst alert?

$ELAB triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: PMGC Holdings Reports Preclinical EL-32 Results with Semaglutide. Key points: - Preclinical 8-week DIO mouse study evaluated EL-32 probiotic platform in combination with semaglutide - Identified preliminary lean-mass finding at highest dose; follow-on study planned for Q1 2027 - Remains very early stage preclinical research without human clinical data

How did $ELAB stock react after the SEC filing?

After the SEC 8-K for $ELAB, observed market reaction: T0 price $1.68. Past moves do not guarantee future results.

Where can I get real-time $ELAB SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ELAB via Telegram and the VIP Web Terminal from €10/month.

$ELAB

$ELAB – PMGC Holdings Reports Preclinical EL-32 Results with Semaglutide

PMGC Holdings Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $ELAB

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+1.5 / 10)

Preclinical 8-week DIO mouse study evaluated EL-32 probiotic platform in combination with semaglutide
Identified preliminary lean-mass finding at highest dose; follow-on study planned for Q1 2027
Remains very early stage preclinical research without human clinical data

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →